Biomedix Dialysis, LLC – Trademark Portfolio

Entity Type: 16

Biomedix Dialysis, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 37 (Building & Construction) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BION. The owner is based in Pawtucket, RI.

59 Prospect Street

Pawtucket, RI 02860

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BION
BION
Registered 2021
BION
BION
Registered 2020

Trademark Classifications

Biomedix Dialysis, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

37
Building & Construction (2 filings)

Building construction; repair; installation services

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Biomedix Dialysis, LLC have?

Biomedix Dialysis, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Biomedix Dialysis, LLC file in?

Biomedix Dialysis, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 37 (Building & Construction), Class 41 (Education & Entertainment). Class 37 covers building construction; repair; installation services.

What are Biomedix Dialysis, LLC's most well-known trademarks?

Biomedix Dialysis, LLC's registered trademark portfolio includes well-known marks such as BION. These are among 2 currently registered trademarks in the portfolio.

What is Biomedix Dialysis, LLC's trademark registration success rate?

Biomedix Dialysis, LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.